{
  "id": 4589055,
  "title": "FDA approves drug that doubles survival for advanced pancreatic cancer",
  "url": "https://urgent.news/2026/08/31/fda-approves-drug-that-doubles-survival-for-advanced-pancreatic-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-31T05:47:03.000Z",
  "source": {
    "name": "Ajel English",
    "slug": "ajel-english",
    "url": "https://english.ajel.sa/lifestyle/3dtxboe8a"
  },
  "original_language": "en",
  "account": null,
  "summary": "The US FDA has approved daraxonrasib for metastatic pancreatic cancer after trials showed it doubled survival compared to chemotherapy.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Arabian Business",
        "title": "FDA approves new pancreatic cancer drug months ahead of schedule",
        "url": "https://urgent.news/2026/08/29/fda-approves-new-pancreatic-cancer-drug-months-ahead-of-schedule",
        "published": "2026-08-29T12:26:39.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}